EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of Two Field Deployable PCR Platforms for SARS-CoV-2 and Influenza A and B Viruses’ Detection

Hakim Bouamar, Grace M Reed iD, Wanda Lyon, Hector Lopez, Anna Ochoa, Susana N Asin iD

Pathogens · 2025

DOI: 10.3390/pathogens14010027 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pathogens, 2025. Verfasst von Hakim Bouamar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Molecular Detection, 59th Medical Wing/Science & Technology, Joint Base San Antonio, Lackland, TX 78236, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, Influenza B virus, COVID-19, Influenza, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Defense Health Agency, FY2021 DHA Restoral.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Respiratory viral infections are a major public health challenge and the most diagnosed medical condition, particularly for individuals living in close proximity, like military personnel. We compared the sensitivity and specificity of the Biomeme FranklinTM and Truelab® RT-PCR thermocyclers to determine which platform is more sensitive and specific at detecting SARS-CoV-2 and influenza A and B viruses. Methodology: RNA extracted from nasopharyngeal swabs of infected and uninfected individuals was tested on the Biomeme FranklinTM at Lackland and the Truelab® at Wright Patterson Air Force bases.

Results

We found an 88% and 71% positivity rate in SARS-CoV-2-infected samples tested on Biomeme and Truelab®, respectively. Likewise, we found a 49% and 80% positivity rate in influenza-positive samples tested on Biomeme and Truelab®, respectively. One hundred percent of uninfected swab samples tested negative for SARS-CoV-2 on both platforms. Conversely, 91% and 100% of uninfected swabs tested negative for flu on Biomeme and Truelab®, respectively. Significance: Differences in specificity and sensitivity in detection of SARS-CoV-2 and influenza between Biomeme and Truelab® suggest that Truelab® is a more promising and potentially deployable diagnostic platform for SARS-CoV-2 and influenza viruses’ detection in an austere environment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Influenza B virusCOVID-19Influenza, HumanInfluenza A virusPolymerase Chain ReactionCOVID-19 Nucleic Acid TestingHumansSensitivity and SpecificityNasopharynxRNA, Viral

Stichwörter der Autor:innen

BiomemeMolBioSARS-CoV-2influenza A and Bpoint-of-care diagnostic test

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Center for Advanced Molecular Detection, 59th Medical Wing/Science & Technology, Joint Base San Antonio, Lackland, TX 78236, USA.
  • 711th Human Performance Wing, Airman Systems Directorate, Air Force Research Laboratory, Wright-Patterson AFB, Dayton, OH 45433, USA.
  • US Army FUTURE COMMANDS, Fort Sam Houston, San Antonio, TX 78234, USA.

ORCID-Profile: Grace M Reed, Susana N Asin

Förderung

  • Defense Health Agency
  • FY2021 DHA Restoral

Zitieren

APA

Bouamar, H., Reed, G. M., Lyon, W., Lopez, H., Ochoa, A., & Asin, S. N. (2025). Comparison of Two Field Deployable PCR Platforms for SARS-CoV-2 and Influenza A and B Viruses’ Detection. Pathogens. https://doi.org/10.3390/pathogens14010027

Vancouver

Bouamar H, Reed GM, Lyon W, Lopez H, Ochoa A, Asin SN. Comparison of Two Field Deployable PCR Platforms for SARS-CoV-2 and Influenza A and B Viruses’ Detection. Pathogens. 2025. doi:10.3390/pathogens14010027

BibTeX
@article{Bouamar2025,
  author = {Bouamar, Hakim and Reed, Grace M and Lyon, Wanda and Lopez, Hector and Ochoa, Anna and Asin, Susana N},
  title = {Comparison of Two Field Deployable PCR Platforms for SARS-CoV-2 and Influenza A and B Viruses’ Detection},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14010027}
}
Kostenlos starten →